Agile Therapeutics reported -15573000 in Operating Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Adma Biologics ADMA:US $ -21.48M 8.29M
Agile Therapeutics AGRX:US -15573000 6.78M
Bayer BAYN:GR 4.21B 2.19B
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
JAZZ PHA JAZZ:US $ 85.55M 2M
Johnson & Johnson JNJ:US $ 5840M 22M
Merk MRK:US $ 4927M 642M
Pacira Pharmaceuticals PCRX:US $ 31.24M 13.84M
Pain Therapeutics PTIE:US $ -17821000 3.38M
Pfizer PFE:US $ 12102M 2229M
Teva Pharmaceutical Industries TEVA:US $ -949M 236M
Therapeuticsmd TXMD:US -34609000 783K